Inventor
TRAN THUY-ANH
US30 patents
⚠️ This page may combine multiple inventors who share the name “TRAN THUY-ANH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
23 patentsUS9328107B2May 3, 2016
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
USRE45337EJan 13, 2015
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC11 citations92
USRE45336EJan 13, 2015
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
US9221755B2Dec 29, 2015
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC11 citations83
US9012478B2Apr 21, 2015
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC4 citations83
US10479797B2Nov 19, 2019
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC9 citations82
US11098034B2Aug 24, 2021
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations72
US10689372B2Jun 23, 2020
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations72
US10214518B2Feb 26, 2019
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC2 citations72
US9663500B2May 30, 2017
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC3 citations72
US11560386B2Jan 24, 2023
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC1 citations71
US10927123B2Feb 23, 2021
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC2 citations71
US10793529B2Oct 6, 2020
Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators
ARENA PHARM INC1 citations71
US10662200B2May 26, 2020
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC3 citations71
US11339172B2May 24, 2022
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto
ARENA PHARM INC3 citations70
US10668033B2Jun 2, 2020
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC4 citations70
US9987252B2Jun 5, 2018
Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations62
US11987588B2May 21, 2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto
ARENA PHARM INC0 citations60
US10138210B2Nov 27, 2018
Substituted pyridazines as prostacyclin receptor modulators
ARENA PHARM INC1 citations60
USRE50267EJan 14, 2025
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations59
US12559462B2Feb 24, 2026
Pyrimidine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations52
US10450276B2Oct 22, 2019
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
US9365511B2Jun 14, 2016
Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders
ARENA PHARM INC0 citations51
TEEGARDEN BRADLEY
4 patentsUS8664258B2Mar 4, 2014
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY14 citations91
US8148417B2Apr 3, 2012
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY21 citations91
US8148418B2Apr 3, 2012
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY16 citations91
US8680119B2Mar 25, 2014
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY11 citations82